ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685272 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685272; 2) Community: the network communities that were significantly associated with the response to NSC 685272; 3) Molecule: the relationships between components within communities and NSC 685272; 4) MDR: the compounds that were significantly associated with the NSC 685272.

NSC Compound Enrichment Correlation
NSC 95382 Camptothecin Derivative 0.0467178916101842 0.19434532
NSC 758662 Lovastatin [USAN] 3.06846480290521e-005 0.11635583
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 3.26903279404692e-005 0.13017483
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 3.88440367201721e-005 -0.25253886
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 3.88440367201721e-005 -0.37571137
Total:82  Current:82    [First] [Prev] [Next] [Last]